| Patent | Date |
|---|
TPP-1 formulations and methods for treating CLN2 disease
Grant 11,229,687 - Lester , et al. January 25, 2 | 2022-01-25 |
TPP-1 Formulations and Methods for Treating CLN2 Disease
App 20200353059 - Lester; Thomas ; et al. | 2020-11-12 |
Variants of C-type natriuretic peptide
Grant RE48,267 - Wendt , et al. October 20, 2 | 2020-10-20 |
TPP-1 formulations and methods for treating CLN2 disease
Grant 10,758,598 - Lester , et al. Sep | 2020-09-01 |
Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
App 20200246434 - Kind Code | 2020-08-06 |
Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
App 20200246433 - Kind Code | 2020-08-06 |
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
Grant 10,646,550 - Bullens , et al. | 2020-05-12 |
Compositions Of Prokaryotic Phenylalanine Ammonia-lyase Variants And Methods Of Using Compositions Thereof
App 20190345475 - Okhamafe; Augustus O. ; et al. | 2019-11-14 |
TPP-1 Formulations and Methods for Treating CLN2 Disease
App 20190216905 - Lester; Thomas ; et al. | 2019-07-18 |
Dry Blend Formulation Of Tetrahydrobiopterin
App 20190160070 - Chou; Tianwei ; et al. | 2019-05-30 |
TPP-1 formulations and methods for treating CLN2 disease
Grant 10,279,015 - Lester , et al. | 2019-05-07 |
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
Grant 10,221,408 - Okhamafe , et al. | 2019-03-05 |
Use Of C-type Natriuretic Peptide Variants To Treat Skeletal Dysplasia
App 20180207239 - BULLENS; SHERRY ; et al. | 2018-07-26 |
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
Grant 9,907,834 - Bullens , et al. March 6, 2 | 2018-03-06 |
Variants of C-type natriuretic peptide
Grant RE46,707 - Wendt , et al. February 13, 2 | 2018-02-13 |
Variants of C-Type Natriuretic Peptide
App 20170051033 - Wendt; Daniel J. ; et al. | 2017-02-23 |
Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof
Grant 9,567,572 - Koppaka , et al. February 14, 2 | 2017-02-14 |
Use Of C-type Natriuretic Peptide Variants To Treat Skeletal Dysplasia
App 20170028023 - Bullens; Sherry ; et al. | 2017-02-02 |
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring
App 20170000793 - Oppenheimer; Daniel I. ; et al. | 2017-01-05 |
Compositions Of Prokaryotic Phenylalanine Ammonia-lyase Variants And Methods Of Using Compositions Thereof
App 20160362675 - Okhamafe; Augustus O. ; et al. | 2016-12-15 |
Tpp-1 Formulations And Methods For Treating Cln2 Disease
App 20160324942 - Lester; Thomas W. ; et al. | 2016-11-10 |
Variants of C-Type Natriuretic Peptide
App 20160256553 - Wendt; Daniel J. ; et al. | 2016-09-08 |
Manufacture of Active Highly Phosphorylated Human N-Acetylgalactosamine-6-Sulfatase and Uses Thereof
App 20160186149 - Koppaka; Vish ; et al. | 2016-06-30 |
Dry Blend Formulation Of Tetrahydrobiopterin
App 20160074406 - Chou; Tianwei ; et al. | 2016-03-17 |
Dry blend formulation of tetrahydrobiopterin
Grant 9,216,178 - Chou , et al. December 22, 2 | 2015-12-22 |
Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof
Grant 8,765,437 - Koppaka , et al. July 1, 2 | 2014-07-01 |
Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-q- uinolin-2-one lactic acid salts
Grant 8,614,216 - Okhamafe , et al. December 24, 2 | 2013-12-24 |
Variants of C-type natriuretic peptide
Grant 8,598,121 - Wendt , et al. December 3, 2 | 2013-12-03 |
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring
App 20130237543 - Oppenheimer; Daniel I. ; et al. | 2013-09-12 |
Salts of benzimidazolyl pyridyl ethers and formulations thereof
Grant 8,501,785 - Gullapalli , et al. August 6, 2 | 2013-08-06 |
Dry Blend Formulation Of Tetrahydrobiopterin
App 20130108694 - Chou; Tianwei ; et al. | 2013-05-02 |
Compositions Of Prokaryotic Phenylalanine Ammonia-lyase Variants And Methods Of Using Compositions Thereof
App 20130039898 - Okhamafe; Augustus O. ; et al. | 2013-02-14 |
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties
App 20130018058 - Cai; Shaopei ; et al. | 2013-01-17 |
Variants of C-type Natriuretic Peptide
App 20120316114 - Wendt; Daniel J. ; et al. | 2012-12-13 |
Solid forms of a Raf kinase inhibitor
Grant 8,324,389 - Hashash , et al. December 4, 2 | 2012-12-04 |
Methods of administering tetrahydrobiopterin
Grant RE43,797 - Oppenheimer , et al. November 6, 2 | 2012-11-06 |
Methods For Synthesizing Quinolinone Compounds
App 20120277434 - Cai; Shaopei ; et al. | 2012-11-01 |
Crystalline And Other Forms Of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-q- Uinolin-2-one Lactic Acid Salts
App 20120208825 - Okhamafe; Augustus O. ; et al. | 2012-08-16 |
Manufacture Of Active Highly Phosphorylated Human N-acetylgalactosamine-6-sulfatase And Uses Thereof
App 20120189605 - Koppaka; Vish ; et al. | 2012-07-26 |
Variants of C-type natriuretic peptide
Grant 8,198,242 - Wendt , et al. June 12, 2 | 2012-06-12 |
Crystalline And Other Forms Of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-q- Uinolin-2-one Lactic Acid Salts
App 20110178097 - Okhamafe; Augustus O. ; et al. | 2011-07-21 |
Variants of C-Type Natriuretic Peptide
App 20100297021 - Wendt; Daniel J. ; et al. | 2010-11-25 |
Compositions Of Prokaryotic Phenylalanine Ammonia-lyase And Methods Of Treating Cancer Using Compositions Thereof
App 20100278802 - KAKKIS; Emil D. ; et al. | 2010-11-04 |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
Grant 7,790,433 - Kakkis , et al. September 7, 2 | 2010-09-07 |
Solid Forms of a Raf Kinase Inhibitor
App 20100209418 - Hashash; Ahmad ; et al. | 2010-08-19 |
Salts Of Benzimidazolyl Pyridyl Ethers And Formulations Thereof
App 20100168060 - Gullapalli; Rampurna ; et al. | 2010-07-01 |
Compositions of Prokaryotic Phenylalanine Ammonia-Lyase and Methods of Treating Cancer Using Compositions Thereof
App 20090263369 - KAKKIS; EMIL D. ; et al. | 2009-10-22 |
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties
App 20090181979 - Cai; Shaopei ; et al. | 2009-07-16 |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
Grant 7,537,923 - Kakkis , et al. May 26, 2 | 2009-05-26 |
Compositions Of Prokaryotic Phenylalanine Ammonia-lyase And Methods Of Treating Cancer Using Compositions Thereof
App 20090047265 - Kakkis; Emil D. ; et al. | 2009-02-19 |
Crystalline forms of 9-(S)-erythromycylamine
App 20050250714 - Lin, Kangwen L. ; et al. | 2005-11-10 |
Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
App 20050209247 - Cai, Shaopei ; et al. | 2005-09-22 |
Methods for synthesizing quinolinone compounds
App 20050137399 - Cai, Shaopei ; et al. | 2005-06-23 |
| 